Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Obamacare enrollment declines as US subsidies expire - 2The Most Compelling Innovation Advancements Somewhat recently
- 3PHOTO ESSAY: Scientists trying to unravel one of the body's biggest mysteries
- 4Scientists detect X-ray glow from interstellar comet 3I/ATLAS extending 250,000 miles into space
- 5'Harmonious' meeting between Merz, Lula despite Belém controversy
- Finding the Universe of Craftsmanship: Individual Encounters in Imagination
- Bomb blast in packed Nigerian mosque kills five
- Support Your Investment funds with These Individual accounting Thoughts
- The most effective method to Guarantee Scholastic Honesty in Web-based Degrees
- Japan prepares to restart world's biggest nuclear plant, 15 years after Fukushima
- Watching ‘Home Alone’ with the kids this holiday season? Brace yourself for '6-7.'
- Online business Stages for Little Retailers
- Vinicultural Investigation: A Survey of \Enjoying Fine Vintages\ Wine sampling
- From Fledgling to Master: Self-awareness in a Side interest
